Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation?

Journal of Alzheimer's Disease

Volumn 39, Issue 1, 2014, Pages 169-179

  Asti, Annalia ^a   Gioglio, Luciana ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Alzheimer's disease; amyloid ; Escherichia coli; lipopolysaccharide; transmission electron microscopy

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; ESCHERICHIA COLI ENDOTOXIN; LIPOPOLYSACCHARIDE;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; IN VITRO STUDY; INCUBATION TEMPERATURE; KINETICS; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

ALZHEIMER'S DISEASE; AMYLOID-Β; ESCHERICHIA COLI; LIPOPOLYSACCHARIDE; TRANSMISSION ELECTRON MICROSCOPY;

AMYLOID BETA-PEPTIDES; ANIMALS; ENDOTOXINS; ESCHERICHIA COLI; HUMANS; LIPOPOLYSACCHARIDES; PEPTIDE FRAGMENTS; PLAQUE, AMYLOID;

EID: 84892770285     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131394     Document Type: Article

References (81)

1. Iversen LL, Mortishire-Smith RJ, Pollack SJ, Shearman MS (1995) The toxicity in vitro of beta-amyloid protein. Biochem J 311, 1-16.
2. Serpell LC, Sunde M, Benson MD, Tennent GA, Pepys MB, Fraser PE (2000) The protofilament substructure of amyloid fibrils. J Mol Biol 300, 1033-1039.
3. Barrow CJ, Zagorski M (1991) Solution structures of beta peptide and its constituent fragments: Relation to amyloid deposition. Science 253, 179-182. (Pubitemid 21917135)
4. Botta L, Valli P, Asti A, Perin P, Zucca G, Racchi M, Govoni S, Pascale A (2001) Beta amyloid-induced disruption of ionic balance: Studies on the isolated frog labyrinth. Neuroreport 12, 2493-2497. (Pubitemid 32682209)
5. Soreghan B, Kosmoski J, Glabe C (1994) Surfactant properties of Alzheimer's A beta peptides and the mechanism of amyloid aggregation. J Biol Chem 269, 28551-28554. (Pubitemid 24366683)
6. Hauss-Wegrzyniak B, Vranlak PD, Wenk GL (2000) LPSinduced neuroinflammatory effects do not recover with time. Neuroreport 11, 1759-1763. (Pubitemid 30350348)
7. De Chiara G, Marcocci ME, Sgarbanti R, Civitelli L, Ripoli C, Piacentini R, Garaci E, Grassi C, Palamara AT (2012) Infectious agents and neurodegeneration. Mol Neurobiol 46, 614-638.
8. Ling YS, Mao HP, Zhong AC, Guo YC (1991) The effects of Escherichia coli and its endotoxin on amyloidogenesis in ducks. Vet Pathol 28, 519-523.
9. Zoltowska A, Wrzolkowa T (1973) Experimental amyloidosis in hamsters. J Pathol 109, 93-100.
10. Bailey CH (1916) The production of Amyloid disease and chronic nephritis in rabbits by repeated intravenous injection of living colon bacilli. J Exp Med 23, 773-790.
11. Barth WF, Gordon JK, Willerson JT (1968) Amyloidosis induced in mice by Escherichia coli endotoxin. Science 162, 694-695.
12. Bowery NG, Bagetta G, Nistico G (1992) Intrahippocampal tetanus toxin produces generalized convulsions and neurodegeneration in rats: Antagonism by NMDA receptor blockers. Epilepsy Res Suppl 9, 249-256.
13. Mattson MP (2004) Infectious agents and age-related neurodegenerative disorders. Ageing Res Rev 3, 105-120. (Pubitemid 38177441)
14. Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum-Hudson JA, Hudson AP (1998) Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol 187, 23-42. (Pubitemid 28383127)
15. Ǵerard HC, Wildt KL, Whittum-Hudson J, Lai Z, Ager J Hudson AP (2005) The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype. Microb Pathog 39, 19-26. (Pubitemid 41021657)
16. Paradowski B, JaremkoM, DoboszT, Leszek J, NogaL(2007) Evaluation of CSF Chlamydia pneumoniae, CSF-tau, and CSFAbeta42 in Alzheimer's disease and vascular dementia. J Neurol 254, 154-159. (Pubitemid 46356046)
17. Miklossy J (2011) Emerging role of pathogens in Alzheimer's disease. Expert Rev Mol Med 13, e30.
18. Miklossy J (2008) Biology and neuropathology of dementia in syphilis and Lyme disease. In Dementias, Handbook of Clinical Neurology, Vol. 89, Duyckaerts C, Litvan I, eds. Elsevier, Edinburgh, London, pp. 825-844.
19. Miklossy J (1993) Alzheimer's disease-a spirochetosis Neuroreport 4, 841-848.
20. Kamer AR, Dasanayake AP, Craig RG, Glodzik-Sobanska L, Bry M, de Leon MJ (2008) Alzheimer's disease and peripheral infections: The possible contribution from periodontal infections, model and hypothesis. J Alzheimers Dis 13, 437-449. (Pubitemid 352039026)
21. Pihlstrom BL, Michalowicz BS, Johnson NW (2005) Periodontal diseases. Lancet 366, 1809-1820. (Pubitemid 41642647)
22. Gibson FC III, Hong C, Chou HH, Yumoto H, Chen J, Lien E, Wong J, Genco CA (2004) Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 109, 2801-2806. (Pubitemid 38737928)
23. Marshall BJ,Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1, 1311-1315.
24. Kountouras J, Tsolaki M, Gavalas E, Boziki M, Zavos C, Karatzoglou P, Chatzopoulos D, Venizelos I (2006) Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 66, 938-940. (Pubitemid 43739779)
25. Kountouras J, Boziki M, Gavalas E, Zavos C, Deretzi G, Grigoriadis N, Tsolaki M, Chatzopoulos D, Katsinelos P, Tzilves D, Zabouri A, Michailidou I (2009) Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease. Int J Neurosci 119, 765-777.
26. Malaguarnera M, Bella R, Alagona G, Ferri R, Carnemolla A, Pennisi G (2004) Helicobacter pylori and Alzheimer's disease: A possible link. Eur J Intern Med 15, 381-386. (Pubitemid 39452742)
27. Laitinen K, Laurila A, Pyḧal̈a L, Leinonen M, Saikku P (1997) Chlamydia pneumonia infection induces inflammatory changes in the aortas of rabbits. Infect Immun 65, 4832-4835. (Pubitemid 27463264)
28. Saikku P (1999) Epidemiology of Chlamydia pneumoniae in atherosclerosis. Am Heart J 138(Suppl), 500-503.
29. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D,CammAJ, NorthfieldTC(1994) Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71, 437-439. (Pubitemid 2068912)
30. Martin de Argila C, Boixeda D, Canton R, Gisbert GP, Fuertes A(1995) High seroprevalence of Helicobacter pylori infection in coronary heart disease. Lance 346, 310.
31. Martin RJ (2006) Infections and asthma. Clin Chest Med 27, 87-98.
32. Marttila RJ, Arstila P, Nikoskelainen J, Halonen PE, Rinne UK (1977) Viral antibodies in the sera from patients with Parkinson disease. Eur Neurol 15, 25-33. (Pubitemid 8078920)
33. Rott R, Herzog S, Fleischer B, Winokur A, Amsterdam J, DysonW,KoprowskyH(1985) Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science 228, 755-756. (Pubitemid 15063686)
34. Beaman BL (1994) Bacteria and neurodegeneration. In Neurodegenerative Diseases, Caino D, ed. W.B. Saunders, Orlando, FL, pp. 319-338.
35. Langford D, Masliah E (2003) The emerging role of infectious pathogens in neurodegenerative diseases. Exp Neurol 184, 553-555. (Pubitemid 38182785)
36. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R (2005) Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65, 545-551. (Pubitemid 41170713)
37. Merril CR (2013) Is sporadic Alzheimer's disease associated with diphteria toxin J Alzheimers Dis 34, 595-600.
38. Otzen D, Nielsen PH (2008)We find them here, we find them there: Functional bacterial amyloid. Cell Mol Life Sci 65, 910-927.
39. Chapman MR, Robinson LS, Pinkner JS, Roth R, Heuser J, Hammar M, Normark S, Hulthren SJ (2002) Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 295, 851-855. (Pubitemid 34118365)
40. Johannsen L (1993) Biological properties of bacterial peptidoglycan. APMIS 101, 337-344.
41. Lehman TJ, Allen JB, Plots PH,Wilder RL (1983) Polyarthritis in rats following the systemic injection of Lactobacillus casei cell walls in aqueous suspension. Arthritis Rheum 26, 1259-1265. (Pubitemid 13017183)
42. Fleming TJ, Wallsmith DE, Rosenthal RS (1986) Arthropathic properties of gonococcal peptidoglycan fragments: Implications for the pathogenesis of disseminated gonococcal disease. Infect Immun 52, 600-608. (Pubitemid 16117822)
43. Schwab JH (1993) Phlogistic properties of peptidoglycanpolysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans. Infect Immun 61, 4535-4539. (Pubitemid 23320502)
44. Heiss LN, Lancaster JR, Corbett JA, Goldman WE (1994) Epithelial autotoxicity of nitric oxide: Role in the respiratory cytopathology of pertussis. Proc Natl Acad Sci USA 91, 267-270. (Pubitemid 24018685)
45. Kim HS, Lee JH, Lee JP, Kim EM, Chang KA, Park CH, Jeong SJ, Wittendorp MC, Seo JH, Choi SH, Suh YH (2002) Amyloid-peptide induces cytochrome C release from isolated mitochondria. Neuroreport 13, 1989-1993.
46. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992). Amyloidpeptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12, 376-389.
47. Laferla FM (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 3, 862-872.
48. Urosevic N, Martins RN (2008) Infection and Alzheimer's disease: The APOE epsilon4 connection and lipid metabolism. J Alzheimers Dis 13, 421-435. (Pubitemid 352039025)
49. Licastro F, Porcellini E, Caruso C, Lio D, Corder EH (2007) Genetic risk profiles for Alzheimer's disease: Integration of APOE genotype and variants that up-regulate inflammation. Neurobiol Aging 28, 1637-1643. (Pubitemid 47384944)
50. Pike CJ, Burdick D,Walencewicz AJ, Glabe CG, CotmanCW (1993) Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state. J Neurosci 13, 1676-1687. (Pubitemid 23095409)
51. Yankner BA, Duffy LK, Kirschne DA (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides. Science 250, 279-282.
52. Lomakin A, Chung DS, Benedek GB, Kirschner DA, Teplow DB (1996) On the nucleation and growth of amyloid betaprotein fibrils: Detection of nuclei and quantitation of rate constant. Proc Natl Acad Sci USA 93, 1125-1129. (Pubitemid 26054370)
53. Chirita CN, Necula M, Kuret J (2003) Anionic micelles and vesicles induce tau fibrillization in vitro. J Biol Chem 278, 25644-25650. (Pubitemid 36835318)
54. Yong W, Lomakin A, Kirkitadze MD, Teplow DB, Chen SH, Benedek GB (2002) Structure determination of micellelike intermediates in amyloid beta-protein fibril assembly by using small angle neutron scattering. Proc Natl Acad SciUS A 99, 150-154. (Pubitemid 34060332)
55. Lomakin A, Teplow DB, Kirschner DA, Benedek GB (1997) Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc Natl Acad Sci USA 94, 7942-7947. (Pubitemid 27343754)
56. Cribbs DH, AzizehBY, CotmanCW, LaferlaFM(2000) Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's A-peptide. Biochemistry 39, 5988-5994. (Pubitemid 30327072)
57. Satpute-Krishnan P, DeGiorgis JA, Bearer EL (2003) Fast anterograde transport of herpes simplex virus: Role for the amyloid precursor protein of Alzheimer's disease. Aging Cell 2, 305-318.
58. Bolintineanu D, Hazrati E, Kaznessis YN (2009) Antimicrobial mechanism of pore-forming protegrin peptides:100 pores to kill E. coli. Peptides 31, 1-8.
59. Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Bradley, Ingelsson M, Hyman B, Mark A, Burton MA, Goldstein LE, Duong S, Tanzi RE, Lee RD (2010) The Alzheimer's disease associated amyloid beta-protein is an antimicrobial peptide. PLoS One 5, 1-10.
60. Alzheimer A (1911) Ü ber eigenartige Krankheitsfälle des sp̈ateren Alters. Z Ges Neurol Psychiat 4, 356-385.
61. Miklossy J, Kis A, Radenovic A, Miller L, Forro L, Martins R, Reiss K, Darbinian N, Darekar P, Mihaly L, Khalili K (2006) Beta-amyloid depositing and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol Aging 27, 228-236. (Pubitemid 43038546)
62. Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42, 1097-1105. (Pubitemid 16236926)
63. Huang SH, Stins MF, Kim KS (2000) Bacterial penetration across the blood-brain barrier during the development of neonatal meningitis. Microbes Infect 2, 1237-1244.
64. Inestrosa NC, Alvarez A, Perez CA, Moreno RD, Vicente M, Linker C, Casanueva OI, Soto C, Garrido J (1996) Acetylcholinesterase accelerates assembly of amyloid-peptides into Alzheimer's fibrils: Possible role of the peripheral site of the enzyme. Neuron 16, 881-891.
65. Sberna G, Saez-Valero J, Li QX, Czech C, Beyreuther K, Masters CL, Mclean CA, Small DH (1998) Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the-amyloid protein precursor of Alzheimer's disease. J Neurochem 71, 723-731. (Pubitemid 28480420)
66. Saez-Valero J, De Ceballos ML, Small DH, De Felipe C (2002) Changes in molecular isoform distribution of acetylcholinesterase in rat cortex and cerebrospinal fluid after intracerebroventricular administration of amyloid-peptide. Neurosci Lett 325, 199-202. (Pubitemid 34603529)
67. Carvajal FJ, Inestrosa NC (2011) Interactions of AChE with A-ggregates in Alzheimer's brain: Therapeutic relevance of IDN 5706. Front Mol Neurosci 4, 1-11.
68. Luchi M, Morrison DC (2000) Comparable endotoxic properties of lipopolysaccharides are manifest in diverse clinical isolates of gram-negative bacteria. Infect Immun 68, 1899-1904. (Pubitemid 30164815)
69. Sullivan ER (1998) Molecular genetics of biosurfactant production. Current Opin Biotechnol 9, 263-269. (Pubitemid 28291176)
70. Cohen AS (1965) The constitution and genesis of amyloid. Int Rev Exp Pathol 4, 159-243.
71. Leinonen M, Saikku P (2000) Infections and atherosclerosis. Scand Cardiovasc J 34, 12-20. (Pubitemid 30342749)
72. Crack PJ, Bray PJ (2007) Toll-like receptors in the brain and their potential roles in neuropathology. Immunol Cell Biol 85, 476-480. (Pubitemid 47367513)
73. Lorenz E, Mira JP, Frees KL, Schwartz DA (2002) Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 162, 1028-1032. (Pubitemid 34492532)
74. Akira S, Takeda K (2004) Functions of toll-like receptors: Lessons from KO mice. C R Biol 327, 581-589. (Pubitemid 38979508)
75. Ma J, Yee A, Brewer HB Jr, Das S, Potter H (1994) Amyloid-associated proteins alpha antichymotrypsin and apolipoprotein E promote assembly of Alzheimer betaprotein into filaments. Nature 372, 92-94.
76. Harris JR (2002) In vitro fibrillogenesis of the amyloid B142 peptide: Cholesterol potentiation and aspirin inhibition. Micron 33, 609-626. (Pubitemid 35426586)
77. Jarrett JT, Lansbury PT (1992) Amyloid fibril formation requires a chemically discriminating nucleation event: Studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry 31, 12345-12352. (Pubitemid 23163109)
78. Perry VH, Cunningham C, Holmes C (2007) Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol 7, 161-167. (Pubitemid 46174862)
79. Mawanda F, Wallace R (2013) Can infections cause Alzheimer's disease Epidemiol Rev 35, 161-180.
80. Holmes C, Cotterell D (2009) Role of infection in the pathogenesis of Alzheimer's disease: Implications for treatment. CNS Drugs 23, 993-1002.
81. Inestrosa NC, Dinamarca MC, Alvarez A (2008) Amyloid cholinesterase interactions. Implications for Alzheimer's disease. FEBS J 275, 625-632. (Pubitemid 351160969)